Patents matching “differentiation”

US 12410403

Methods and compositions for inducing hematopoietic cell differentiation

Fate Therapeutics, Inc. · Granted Sep 9, 2025 · Expires Sep 4, 2045

US 12389889

Mouse having a humanized cluster of differentiation 47 gene

REGENERON PHARMACEUTICALS, INC. · Granted Aug 19, 2025 · Expires Aug 14, 2045

US 12385013

Differentiation of pancreatic endocrine cells

Vertex Pharmaceuticals Incorporated · Granted Aug 12, 2025 · Expires Aug 7, 2045

US 12385012

Methods and compositions for inducing hematopoietic cell differentiation

Fate Therapeutics, Inc. · Granted Aug 12, 2025 · Expires Aug 7, 2045

US 12371665

Differentiation of pancreatic endocrine cells

Vertex Pharmaceuticals Incorporated · Granted Jul 29, 2025 · Expires Jul 24, 2045

US 12234460

Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors

REGENERON PHARMACEUTICALS, INC. · Granted Feb 25, 2025 · Expires Feb 20, 2045

US 12215355

Stem cell derived islet differentiation

Vertex Pharmaceuticals Incorporated · Granted Feb 4, 2025 · Expires Jan 30, 2045

US 12173324

Differentiation of pancreatic endocrine cells

Vertex Pharmaceuticals Incorporated · Granted Dec 24, 2024 · Expires Dec 19, 2044

US 12109224

USB1 directed regulation of miRNAs related hematopoietic differentiation and affected in multiple forms of leukemia

The Regents of the University of Colorado, a Body Corporate · Granted Oct 8, 2024 · Expires Oct 3, 2044

US 12054517

Myeloid differentiation factor 2 (MD2) signaling and modulation

The Regents of the University of California · Granted Aug 6, 2024 · Expires Aug 1, 2044

US 12049645

Differentiation of pancreatic endocrine cells

Vertex Pharmaceuticals Incorporated · Granted Jul 30, 2024 · Expires Jul 25, 2044

US 12006516

Differentiation of pancreatic endocrine cells

Vertex Pharmaceuticals Incorporated · Granted Jun 11, 2024 · Expires Jun 6, 2044

US 11999971

Stem cell derived islet differentiation

Vertex Pharmaceuticals Incorporated · Granted Jun 4, 2024 · Expires May 30, 2044

US 11992506

Stem cell derived pancreatic islet differentiation

Vertex Pharmaceuticals Incorporated · Granted May 28, 2024 · Expires May 23, 2044

US 11910788

Mouse having a humanized cluster of differentiation 47 gene

REGENERON PHARMACEUTICALS, INC. · Granted Feb 27, 2024 · Expires Feb 22, 2044

US 11891607

Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors

REGENERON PHARMACEUTICALS, INC. · Granted Feb 6, 2024 · Expires Feb 1, 2044

US 11891436

Monoclonal antibodies to growth and differentiation factor 15 (GDF-15)

Julius-Maximilians-Universitat Wurzburg · Granted Feb 6, 2024 · Expires Feb 1, 2044

US 11760795

Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer

Julius-Maximilians-Universitat Wurzburg · Granted Sep 19, 2023 · Expires Sep 14, 2043

US 11634482

Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer

Julius-Maximilians-Universitat Wurzburg · Granted Apr 25, 2023 · Expires Apr 20, 2043

US 11634688

Methods and compositions for inducing hematopoietic cell differentiation

Fate Therapeutics, Inc. · Granted Apr 25, 2023 · Expires Apr 20, 2043

US 11617769

Methods of transdifferentiation and methods of use thereof

TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Apr 4, 2023 · Expires Mar 30, 2043

US 11525120

Stem cell derived islet differentiation

Vertex Pharmaceuticals Incorporated · Granted Dec 13, 2022 · Expires Dec 8, 2042

US 11512112

Peptide for suppressing osteoclast differentiation and use thereof

CAREGEN CO., LTD. · Granted Nov 29, 2022 · Expires Nov 24, 2042

US 11464856

Combination therapy using inhibitors of human growth and differentiation factor 15 (GDF-15) and immune checkpoint blockers

Julius-Maximilians-Universitat Wurzburg · Granted Oct 11, 2022 · Expires Oct 6, 2042